GREY:ATBPF - Post by User
Comment by
CalgaryATEon Dec 01, 2020 12:00am
231 Views
Post# 32007143
RE:RE:Antibe’s revolutionary pain drug is entering Phase 3 trials
RE:RE:Antibe’s revolutionary pain drug is entering Phase 3 trialsMost recent MD&A, page 4 paragraph 6 will correct your "8 months" to start phase III after finishing phase IIb. Paragraph 7 gives one of the main reasons as to why phase III is starting when it is.
Pandora wrote: UVPGuy wrote: This morning, BNN Bloomberg posted an article about Antibe Therapeutics (TSX: ATE | OTCQB: ATBPF) and their revolutionary pain drug entering Phase 3 trials. The company is a clinical-stage biotechnology company currently leveraging its unique hydrogen sulfide platform to develop safer medicines for pain and inflammation.
“We’ve made tremendous progress this quarter in preparing our lead drug for Phase 3 trials and partnering. We are getting closer to the start of our Phase 3 program, with a total of eight Phase 3-enabling studies now running in parallel.” - Dan Legault, CEO
Read the full article here:
https://www.bnnbloomberg.ca/investors-take-note-antibe-s-revolutionary-pain-drug-is-entering-phase-3-trials-1.1527633 Learn more about Antibe Therapeutics here:
https://antibethera.com/
Just a question from curiosity - June 1 & 2 they announced top line results for Phase llB study. Why does it take 8 months to then get started on Phase lll?